Geneva, March 31 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120895) titled 'ctDNA-guided dynamic monitoring for befotertinib combined with radiotherapy in oligometastatic non-small cell lung cancer with EGFR mutations: a single-arm, multicenter, exploratory study' on March 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Fourth Hospital of Hebei Medical University
Condition:
Non-small cell lung cancer
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-03-25
Target Sample Size: Trial Group:84;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=312036
Published by HT Dig...